# A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

> **NCT00150397** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 112 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Tofimilast

## Key facts

- **NCT ID:** NCT00150397
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 112 (—)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150397, "A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00150397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*